Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705663 · ClinicalTrials.gov registry record
Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 25
- Enrollment target
NCT03705663 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 25 participants.
The verdict
NCT03705663 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Pre-exposure prophylaxis (PrEP) is a daily pill that greatly reduces the risk of transmission of human immunodeficiency virus (HIV), however the barriers to PrEP use for women are understudied and PrEP is underutilized by women. Partnering with the DC Department of Health and the DC Center for AIDS Research (DC-CFAR), the overarching goals are (1) to identify and populate the PrEP cascade for women, (2) to provide a blueprint for family planning providers to integrate HIV prevention into their practices and target evidence-based interventions to the women at highest risk for HIV in their communities, and (3) to evaluate the cost-effectiveness of this intervention. The overarching hypotheses are that (1) the timeline and roadmap to PrEP adoption and the PrEP cascade will be different for cis-gender women than that described for men who have sex with men (MSM) and transgender women, (2) women seeking family planning services will be eligible for and interested in PrEP and family planning providers are ideally situated to provide this care, and (3) provision of PrEP in the family planning setting will be cost-effective. This research proposes to evaluate (1) PrEP cascade of events for women (eligibility for PrEP, acceptability/interest in PrEP, access/linkage to a PrEP program, initiation of PrEP, retention, and adherence to PrEP) and (2) the integration of universal screening for PrEP and PrEP provision into a women's family planning clinic. This research will allow for targeted evidence-based interventions to reach women at high-risk for HIV and will provide a blueprint for the implementation of PrEP services in the family planning setting nationally.
Interventions
- BEHAVIORAL PrEP initiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03705663
The ClinicalTrials.gov registry entry for NCT03705663 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP initiation is the first listed.
NCT03705663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03705663 about?
NCT03705663 is a clinical study titled "Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.". Pre-exposure prophylaxis (PrEP) is a daily pill that greatly reduces the risk of transmission of human immunodeficiency virus (HIV), however the barriers to PrEP use for women are understudied and PrEP is underutilized by women. Partnering with the DC Department of Health and the DC Center for AIDS ...
What is the current status of trial NCT03705663?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-07-01. Estimated completion is 2020-04-27.
What interventions are being tested in trial NCT03705663?
The interventions under investigation include: PrEP initiation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03705663?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.